September 1, 2015

Biotechnology, Food & Drug Administration FDA News

Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles

The National Law Review includes articles impacting the biotech and cleantech fields addressing: licensing and patent issues, intellectual property due diligence, litigation and tax. Content is also included addressing: greenhouse gas (GHG) regulation; mandated emissions reduction legislation; NEPA and CEQA claims, common law nuisance litigation; acquiring and selling emission offset and emission reduction credits and acid rain allowances under the United States Clean Air Act, SCAQMD RECLAIM and other air credit programs.

Date Title Organization
1
Sep
Makers’ Mark Two: Bourbon Distiller Slips another “Handmade” False Advertising Suit Proskauer Rose LLP
1
Sep
Wait Continues for Release of First FSMA Final Rules Armstrong Teasdale
1
Sep
FDA’s New Four-Letter Guidance on Biosimilars Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
31
Aug
Getting Serious about Palcohol: Powdered Alcohol Drinker Biddle & Reath LLP
31
Aug
An Update on Biosimilar Activity in the U.S. Michael Best & Friedrich LLP
30
Aug
Another FTC Conduct Case to Bolster Generic Drug Competition: Pharmaceuticals Charged with Illegal Non-Compete for Generic ADHD Drug Sales Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
28
Aug
What’s in a Name? That Which We Call a Biological Product… Sheppard, Mullin, Richter & Hampton LLP
28
Aug
FDA’s Proposed Naming Convention for Biologics Foley & Lardner LLP
28
Aug
Health Resources and Service Administration (HRSA) Issues Proposed “Omnibus Guidance” Epstein Becker & Green, P.C.
28
Aug
Amgen Inc., et al. v. Sandoz, Inc.: Shall Means Shall . . . Unless It Doesn’t McDermott Will & Emery
27
Aug
Food Standards of Identity Remain a Focus of FDA Regulatory Action Michael Best & Friedrich LLP
27
Aug
Sixth Circuit Assesses Class Action Criteria in Digestive Drug Litigation Squire Patton Boggs (US) LLP
27
Aug
Amgen And Apotex Do The Biosimilar Patent Dance Foley & Lardner LLP
26
Aug
Kyle Bass Loses Round 1 Of IPR Attack Against Pharma/Biotech Patents Foley & Lardner LLP
26
Aug
Trademarking: Capri Sun Says “Respect the Pouch” IMS ExpertServices
26
Aug
State Pharmaceutical Pricing Disclosure Laws: Old Story, New Refrain Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
26
Aug
AmerisourceBergen Guest Post: Solutions to Overcome Reimbursement Challenges in Personalized Medicine Foley & Lardner LLP
26
Aug
Litigation Fallout From All This Supply Chain Transparency Legislation (Or, These Things Have Teeth!) (Or, The Cycle of Misfortune) Squire Patton Boggs (US) LLP
25
Aug
FDA Flunks Mylan’s India Facilities, Finds cGMP Violations Mahany Law
25
Aug
PTAB Denies Institution Of Kyle Bass's Ampyra Patent Challenge Foley & Lardner LLP

Pages

Advertisement

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Tuesday, September 8, 2015
Wednesday, September 9, 2015
Thursday, September 17, 2015
Friday, September 18, 2015 to Saturday, September 19, 2015